Allena Pharmaceuticals ALNA

$ 0.08 3.16%

Quarterly report 2022-Q2
added 08-15-2022

Allena Pharmaceuticals Financial Statements 2011-2024 | ALNA

Annual Financial Statements Allena Pharmaceuticals

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	71.4 M	59.2 M	156 M	40.6 M	-	-	-	-	-	-
Shares	68 M	42 M	22.2 M	20.7 M	4.52 M	-	-	-	-	-	-
Historical Prices	0.383	1.7	2.55	7.01	8.34	-	-	-	-	-	-
Net Income	-48.7 M	-32.8 M	-47.3 M	-35.6 M	-21.6 M	-24.5 M	-14.2 M	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-47.6 M	-32 M	-47.5 M	-35.6 M	-21 M	-24.2 M	-	-	-	-	-
Interest Expense	-38 K	-349 K	-84 K	-13 K	-257 K	-121 K	-7 K	-	-	-	-
EBITDA	-47.3 M	-31.8 M	-46.8 M	-35.5 M	-20.9 M	-24.1 M	-13.8 M	-	-	-	-
Operating Expenses	47.6 M	32 M	46.9 M	35.6 M	21 M	-	-	-	-	-	-
General and Administrative Expenses	12.7 M	11.6 M	9.68 M	8.64 M	5.43 M	4.08 M	2.36 M	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Allena Pharmaceuticals

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	101 M	89.4 M	83 M	76.7 M	57.9 M	55 M	50.8 M	36.3 M	26.9 M	24.7 M	24.7 M	23.5 M	20.9 M	20.8 M	20.8 M	20.8 M	20.7 M	20.7 M	20.7 M	1.34 M	1.34 M	1.34 M	1.34 M	1.34 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-8.44 M	-11.8 M	-10.4 M	-12.7 M	-14 M	-11.6 M	-10.3 M	-8.03 M	-6.98 M	-7.58 M	-11.4 M	-13.3 M	-11.3 M	-11.4 M	-9.61 M	-9.51 M	-8.65 M	-7.88 M	-6.68 M	-4.67 M	-4.63 M	-5.67 M	-6.22 M	-6.14 M	-7.04 M	-5.11 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-6.92 M	-11.6 M	-10.1 M	-12.4 M	-13.7 M	-11.4 M	-9.98 M	-7.92 M	-6.56 M	-7.52 M	-11.3 M	-13.3 M	-11.3 M	-11.6 M	-9.78 M	-9.7 M	-8.14 M	-7.97 M	-6.57 M	-4.36 M	-4.48 M	-5.54 M	-6 M	-6.1 M	-7.04 M	-5.04 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	1 K	-7 K	-	-11 K	-32 K	9 K	-	-4 K	-314 K	-7 K	-	-3 K	-16 K	-11 K	-	15 K	-13 K	-7 K	-	-162 K	-34 K	3 K	-	8 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-6.68 M	-11.4 M	-10.1 M	-12.4 M	-13.5 M	-11.3 M	-9.98 M	-7.8 M	-6.48 M	-7.48 M	-11.3 M	-13.2 M	-11.3 M	-11.5 M	-9.78 M	-9.66 M	-8.11 M	-7.95 M	-6.57 M	-4.31 M	-4.44 M	-5.52 M	-6 M	-6.07 M	-7.04 M	-5.04 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	6.92 M	11.6 M	10.1 M	12.4 M	13.7 M	11.4 M	9.98 M	7.92 M	6.56 M	7.52 M	11.3 M	13.3 M	11.3 M	11.6 M	9.78 M	9.7 M	8.14 M	7.97 M	6.57 M	4.36 M	4.48 M	5.54 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	2.94 M	3.8 M	-	3.41 M	3.6 M	3.56 M	-	2.97 M	2.75 M	2.88 M	-	2.53 M	2.75 M	2.43 M	-	2.39 M	2.28 M	2.04 M	-	1.41 M	1.02 M	1.19 M	-	839 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency